EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Discussion on the Mechanism of Gandoufumu Decoction Attenuates Liver Damage of Wilson’s Disease by Inhibiting Autophagy through the PI3K/Akt/mTOR Pathway Based on Network Pharmacology and Experimental Verification

Lulu Tang iD, Chenling Zhao iD, Jing Zhang iD, Ting Dong iD, Huaizhen Chen iD, Taohua Wei iD, Jiuxiang Wang iD, Wenming Yang iD

Mediators of Inflammation · 2023

DOI: 10.1155/2023/3236911 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Mediators of Inflammation, 2023. Verfasst von Lulu Tang und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neurology, The First Affiliated Hospital of Anhui University of Chinese Medicine, Hefei 230031, China. Hauptthemen laut MEDLINE: Signal Transduction, Hepatolenticular Degeneration. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 41 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Clinical Medical Research Transformation Special Project of Anhui Province, University Natural Science Research Project of Anhui Province, National Natural Science Foundation of China.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Gandoufumu decoction (GDFMD) is a traditional Chinese medicine that has been widely used to treat Wilson’s disease (WD) liver damage patients. However, its specific molecular mechanism currently remains unclear. Autophagy as a key contributor to WD liver damage has been intensely researched in the recent years. Therefore, the aim of this present study is to explore the effect of GDFMD on autophagy in WD liver damage, and the final purpose is to provide scientific evidence for GDFMD treatment in WD liver damage.

Methods

The molecular mechanisms and autophagy-related pathways of GDFMD in the treatment of WD liver damage were predicted using network pharmacology. Copper assay kit was used to determine copper content in serum. Enzyme-linked immunosorbent assay (ELISA) was utilized to quantify serum levels of liver enzymes and oxidative stress-related indicators. Hematoxylin-eosin (HE), Masson, and Sirius red staining were used for the characterization of liver pathological changes. Transmission electron microscopy, immunofluorescence, and Western blot analyses were used to evaluate autophagy activity. The impact of the GDFMD on typical autophagy-related pathway (PI3K/Akt/mTOR pathway) molecules was also assessed via Western blot analysis.

Results

GDFMD effectively attenuated serum liver enzymes, oxidative stress, autophagy, and degree of hepatic histopathological impairment and reduced serum copper content. Through network pharmacological approaches, PI3K/Akt/mTOR pathway was identified as the typical autophagy-related pathway of GDFMD in the treatment of WD liver damage. Treatment with GDFMD activated the PI3K/Akt/mTOR pathway, an effect that was able to be counteracted by LY294002, a PI3K antagonist or Rapa (rapamycin), an autophagy inducer.

Conclusions

GDFMD imparted therapeutic effects on WD through autophagy suppression by acting through the PI3K/Akt/mTOR pathway.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Signal TransductionHepatolenticular DegenerationHumansProto-Oncogene Proteins c-aktPhosphatidylinositol 3-KinasesCopperNetwork PharmacologyTOR Serine-Threonine KinasesAutophagy

Substanzen

Proto-Oncogene Proteins c-aktPhosphatidylinositol 3-KinasesCopperTOR Serine-Threonine Kinases

Autor:innen und Institutionen

  • Department of Neurology, The First Affiliated Hospital of Anhui University of Chinese Medicine, Hefei 230031, China.
  • The First Clinical Medical College, Anhui University of Chinese Medicine, Hefei 230038, China.

ORCID-Profile: Lulu Tang, Chenling Zhao, Jing Zhang, Ting Dong, Huaizhen Chen, Taohua Wei, Jiuxiang Wang, Wenming Yang

Förderung

  • Clinical Medical Research Transformation Special Project of Anhui Province
  • University Natural Science Research Project of Anhui Province
  • National Natural Science Foundation of China
  • Natural Science Foundation of Anhui Province

Zitieren

APA

Tang, L., Zhao, C., Zhang, J., Dong, T., Chen, H., Wei, T., Wang, J., & Yang, W. (2023). Discussion on the Mechanism of Gandoufumu Decoction Attenuates Liver Damage of Wilson’s Disease by Inhibiting Autophagy through the PI3K/Akt/mTOR Pathway Based on Network Pharmacology and Experimental Verification. Mediators of Inflammation. https://doi.org/10.1155/2023/3236911

Vancouver

Tang L, Zhao C, Zhang J, Dong T, Chen H, Wei T, et al. Discussion on the Mechanism of Gandoufumu Decoction Attenuates Liver Damage of Wilson’s Disease by Inhibiting Autophagy through the PI3K/Akt/mTOR Pathway Based on Network Pharmacology and Experimental Verification. Mediators of Inflammation. 2023. doi:10.1155/2023/3236911

BibTeX
@article{Tang2023,
  author = {Tang, Lulu and Zhao, Chenling and Zhang, Jing and Dong, Ting and Chen, Huaizhen and Wei, Taohua and Wang, Jiuxiang and Yang, Wenming},
  title = {Discussion on the Mechanism of Gandoufumu Decoction Attenuates Liver Damage of Wilson’s Disease by Inhibiting Autophagy through the PI3K/Akt/mTOR Pathway Based on Network Pharmacology and Experimental Verification},
  journal = {Mediators of Inflammation},
  year = {2023},
  doi = {10.1155/2023/3236911}
}
Kostenlos starten →